Skip to main content Help with accessibility Skip to main navigation

Recommendations

This section contains a list of the policy recommendations of the Pan Mersey Area Prescribing Committee.

Reviews of the new medicines have been conducted by our pharmacists using a number of resources including National Institute for Health and Clinical Excellence (NICE) which is a Special health Authority (SHA) set up in 1999. It is used to give advice to the NHS on best clinical practice including the clinical and cost effectiveness of drugs and other treatments.

Definitions and Criteria for Categorisation of Medicines

Documents

Green
IBUPROFEN and NAPROXEN (oral formulations)
Date Posted: 25 - Jan - 2017
Body System: Musculoskeletal system
NHS England
ICATIBANT (Firazyr®▼)
Date Posted: 14 - Nov - 2017
Body System: Immune system
Red
INFLIXIMAB infusion (including biosimilars) in rheumatological conditions
Date Posted: 11 - Apr - 2018
Body System: Musculoskeletal system
Amber initiated
Insulin DEGLUDEC 100units/mL and 200 units/mL solution for subcutaneous injection (Tresiba®▼)
Date Posted: 28 - Feb - 2018
Body System: Endocrine System
Amber retained
ITRACONAZOLE for allergic bronchopulmonary aspergillosis
Date Posted: 26 - Jun - 2019
Body System: Anti-infective Respiratory system
Amber initiated
IVABRADINE (Procoralan®) for the treatment of chronic heart failure
Date Posted: 31 - Jan - 2018
Body System: Cardiovascular system
NHS England
IVACAFTOR (Kalydeco®▼)
Date Posted: 14 - Nov - 2017
Body System: Respiratory system
Green
IVERMECTIN 10mg/g cream (Soolantra®)
Date Posted: 30 - Nov - 2018
Body System: Skin
Red
IXEKIZUMAB solution for injection (Taltz®▼) for Plaque Psoriasis
Date Posted: 24 - May - 2017
Body System: Skin
Red
IXEKIZUMAB solution for injection (Taltz®▼) for Psoriatic Arthritis
Date Posted: 02 - Oct - 2018
Body System: Musculoskeletal system